Bipolar Disorder Trial, Recruiting (NCT06488573)

Bipolar Disorder Trial, Recruiting NCT06488573 Sponsor: University of Sao Paulo Condition: Bipolar Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06488573 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Bipolar Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Bipolar Disorder Type I or Type II
You are an adult between 18 and 60 years old (any gender)
You have been taking medication for Bipolar Disorder for at least one month
You are willing to take part and sign a consent form

Who may not be able to join:

Your diet has already been rated as "very good or excellent" based on a specific diet quality assessment (confirm with trial site)
You are currently experiencing a hypomanic or manic episode, based on a standard mood rating scale (confirm with trial site)
You are currently experiencing severe depression, based on a standard depression rating scale (confirm with trial site)
You are considered to be at low risk of heart or cardiovascular disease, based on a standard risk scoring tool (confirm with trial site)
Your Body Mass Index (BMI) is below 25 kg/m², meaning you are in the normal weight range or underweight
You are currently pregnant or breastfeeding
You have been diagnosed with anorexia nervosa or bulimia nervosa
You have been diagnosed with Irritable Bowel Syndrome or any other condition that affects how your digestive system works

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06488573

Sponsor: University of Sao Paulo

Phase: Not Applicable

Status: Recruiting

Condition: Bipolar Disorder

More information: https://clinicaltrials.gov/study/NCT06488573

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Bipolar Disorder Type I or Type II
You are an adult between 18 and 60 years old (any gender)
You have been taking medication for Bipolar Disorder for at least one month
You are willing to take part and sign a consent form

Who may not be able to join:

Your diet has already been rated as "very good or excellent" based on a specific diet quality assessment (confirm with trial site)
You are currently experiencing a hypomanic or manic episode, based on a standard mood rating scale (confirm with trial site)
You are currently experiencing severe depression, based on a standard depression rating scale (confirm with trial site)
You are considered to be at low risk of heart or cardiovascular disease, based on a standard risk scoring tool (confirm with trial site)
Your Body Mass Index (BMI) is below 25 kg/m², meaning you are in the normal weight range or underweight
You are currently pregnant or breastfeeding
You have been diagnosed with anorexia nervosa or bulimia nervosa
You have been diagnosed with Irritable Bowel Syndrome or any other condition that affects how your digestive system works

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Sao Paulo

Registry

ClinicalTrials.gov

Start date

1 April 2026

Est. completion

1 November 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

C reactive protein; Total cholesterol and fractions; Glycemia; Glycated hemoglobin A1C; Triglycerides; HOMA IR; Apoliporpotein B; Cardiovascular risk; Body weight; Body fat percentage; waist circumference

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov